Nation and world at a glance for March 11
Death sentence commuted
MONTGOMERY, Ala. — Alabama Gov. Kay Ivey has commuted the death sentence of a 75-year-old man who was set to be executed this week even though he was not in the building when the victim was killed during a 1991 robbery. Ivey on Tuesday reduced Charles “Sonny” Burton’s sentence to life in prison without the possibility of parole. Burton was sentenced to death for the shooting death of Doug Battle during a 1991 robbery. However, another man shot Battle when Burton had left the building. The shooter’s death sentence was later reduced on appeal to life imprisonment. Ivey said she thought it would be “unjust” to execute Burton, considering that the shooter was spared the death penalty.
Americans unite over steep
increase in gasoline prices
DE SOTO, Iowa — It seems that a country divided on many fronts is finding common ground at the gas pumps. There, the cost of the Iran war is hitting Americans squarely in the wallet and aggravating people across the political spectrum. That was the message from Associated Press interviews Monday with people at gas stations and beyond in five states. The national average gas price was $3.48 a gallon on Monday, up from $2.90 a month ago, before the war, according to tracking by AAA. But in interviews, some owners of electric vehicles expressed renewed gratitude for their vehicle choice as they sit out the sticker shock.
FDA finds little evidence
drug can help fight autism
WASHINGTON — The Food and Drug Administation is approving a generic drug for a very rare genetic disorder, but not for autism. On Tuesday, the U.S. agency said the drug helps children and adults who cannot get enough folate into the brain. That’s a major turnaround from announcements made at a White House news conference in September. At that event, President Donald Trump and the FDA commissioner said the drug was under review for approval in patients with autism. FDA officials say they narrowed the review to the strongest evidence. They say that evidence supports use only in patients with a specific genetic mutation.
The Associated Press



